| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Published online before print July 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
University of South Florida, Department of Medical Microbiology & Immunology, Tampa
@ To whom correspondence should be addressed. E-mail: tklein{at}hsc.usf.edu.
 |
Abstract |
|---|
Studies on the effects of marijuana smoking have evolved into the discovery and description of the endocannabinoid system. To date, this system is composed of two receptors, CB1 and CB2, and endogenous ligands including anandamide, 2-arachidonoyl glycerol, and others. CB1 receptors and ligands are found in the brain as well as immune and other peripheral tissues. Conversely, CB2 receptors and ligands are found primarily in the periphery, especially in immune cells. Cannabinoid receptors are G protein-coupled receptors, and they have been linked to signaling pathways and gene activities in common with this receptor family. In addition, cannabinoids have been shown to modulate a variety of immune cell functions in humans and animals and more recently, have been shown to modulate T helper cell development, chemotaxis, and tumor development. Many of these drug effects occur through cannabinoid receptor signaling mechanisms and the modulation of cytokines and other gene products. It appears the immunocannabinoid system is involved in regulating the brain-immune axis and might be exploited in future therapies for chronic diseases and immune deficiency.
Key Words: marijuana • Th1 cells • chemotaxis • tumor • G protein • CB1
This article has been cited by other articles:
|
|
 |
|
  C. Potenzieri, T. S. Brink, C. Pacharinsak, and D. A. Simone Cannabinoid Modulation of Cutaneous A{delta} Nociceptors During Inflammation J Neurophysiol, November 1, 2008; 100(5): 2794 - 2806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Di Filippo, L A Pini, G P Pelliccioli, P Calabresi, and P Sarchielli Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1224 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Iribarne, V. Torbidoni, K. Julian, J. P. Prestifilippo, D. Sinha, V. Rettori, A. Berra, and A. M. Suburo Cannabinoid Receptors in Conjunctival Epithelium: Identification and Functional Properties Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4535 - 4544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Wacnik, K. M. Luhr, R. H. Hill, H.-G. Ljunggren, K. Kristensson, and M. Svensson Cannabinoids Affect Dendritic Cell (DC) Potassium Channel Function and Modulate DC T Cell Stimulatory Capacity J. Immunol., September 1, 2008; 181(5): 3057 - 3066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fezza, S. Oddi, M. Di Tommaso, C. De Simone, C. Rapino, N. Pasquariello, E. Dainese, A. Finazzi-Agro, and M. Maccarrone Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation J. Lipid Res., June 1, 2008; 49(6): 1216 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher and B. Gao Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G850 - G854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, S. Begum, and R. Viscidi Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers J Natl Cancer Inst, March 19, 2008; 100(6): 407 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Montecucco, F. Burger, F. Mach, and S. Steffens CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1145 - H1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pacher and Z. Ungvari Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1133 - H1134. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, C. L. Cheng, M. Chen, A. Manivannan, L. Cabay, R. G. Pertwee, A. Coutts, and J. V. Forrester Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis J. Leukoc. Biol., September 1, 2007; 82(3): 532 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. McCollum, A. C. Howlett, and S. Mukhopadhyay Anandamide-Mediated CB1/CB2 Cannabinoid Receptor-Independent Nitric Oxide Production in Rabbit Aortic Endothelial Cells J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 930 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bifulco, C. Grimaldi, P. Gazzerro, S. Pisanti, and A. Santoro Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects Mol. Pharmacol., June 1, 2007; 71(6): 1445 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oka, J. Wakui, S. Ikeda, S. Yanagimoto, S. Kishimoto, M. Gokoh, M. Nasui, and T. Sugiura Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice J. Immunol., December 15, 2006; 177(12): 8796 - 8805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bari, P. Spagnuolo, F. Fezza, S. Oddi, N. Pasquariello, A. Finazzi-Agro, and M. Maccarrone Effect of Lipid Rafts on Cb2 Receptor Signaling and 2-Arachidonoyl-Glycerol Metabolism in Human Immune Cells J. Immunol., October 15, 2006; 177(8): 4971 - 4980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev, October 1, 2006; 86(4): 1309 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kimball, C. R. Schneider, N. H. Wallace, and P. J. Hornby Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G364 - G371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Raduner, A. Majewska, J.-Z. Chen, X.-Q. Xie, J. Hamon, B. Faller, K.-H. Altmann, and J. Gertsch Alkylamides from Echinacea Are a New Class of Cannabinomimetics: CANNABINOID TYPE 2 RECEPTOR-DEPENDENT AND -INDEPENDENT IMMUNOMODULATORY EFFECTS J. Biol. Chem., May 19, 2006; 281(20): 14192 - 14206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Carrier, J. A. Auchampach, and C. J. Hillard Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression PNAS, May 16, 2006; 103(20): 7895 - 7900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kurihara, Y. Tohyama, S. Matsusaka, H. Naruse, E. Kinoshita, T. Tsujioka, Y. Katsumata, and H. Yamamura Effects of Peripheral Cannabinoid Receptor Ligands on Motility and Polarization in Neutrophil-like HL60 Cells and Human Neutrophils J. Biol. Chem., May 5, 2006; 281(18): 12908 - 12918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Rao and N. E. Kaminski Cannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 820 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance Endocr. Rev., February 1, 2006; 27(1): 73 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kraft and H. G. Kress Indirect CB2 Receptor and Mediator-Dependent Stimulation of Human Whole-Blood Neutrophils by Exogenous and Endogenous Cannabinoids J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 641 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Van Sickle, M. Duncan, P. J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N. Stella, A. Makriyannis, D. Piomelli, J. S. Davison, et al. Identification and Functional Characterization of Brainstem Cannabinoid CB2 Receptors Science, October 14, 2005; 310(5746): 329 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Engeli, J. Bohnke, M. Feldpausch, K. Gorzelniak, J. Janke, S. Batkai, P. Pacher, J. Harvey-White, F. C. Luft, A. M. Sharma, et al. Activation of the Peripheral Endocannabinoid System in Human Obesity Diabetes, October 1, 2005; 54(10): 2838 - 2843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Shoemaker, B. K. Joseph, M. B. Ruckle, P. R. Mayeux, and P. L. Prather The Endocannabinoid Noladin Ether Acts as a Full Agonist at Human CB2 Cannabinoid Receptors J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 868 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Sipe, N. Arbour, A. Gerber, and E. Beutler Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders J. Leukoc. Biol., July 1, 2005; 78(1): 231 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kishimoto, M. Muramatsu, M. Gokoh, S. Oka, K. Waku, and T. Sugiura Endogenous Cannabinoid Receptor Ligand Induces the Migration of Human Natural Killer Cells J. Biochem., February 1, 2005; 137(2): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oka, S. Ikeda, S. Kishimoto, M. Gokoh, S. Yanagimoto, K. Waku, and T. Sugiura 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils J. Leukoc. Biol., November 1, 2004; 76(5): 1002 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Newton, T. Lu, S. J. Nazian, I. Perkins, H. Friedman, and T. W. Klein The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2 J. Leukoc. Biol., October 1, 2004; 76(4): 854 - 861. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
